Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Hoedemaekers

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
Nederlands Tijdschrift Voor Geneeskunde|November 22, 2019
[Elderly patients in the ICU: extending life to the max?]C Hoedemaekers
Immunologic Research|January 1, 1997
Myasthenia gravis as a prototype autoimmune receptor diseaseA C Hoedemaekers, P J van Breda Vriesman, M H De Baets
European Journal of Immunology|December 1, 1996
Inhibition of experimental autoimmune myasthenia gravis by major histocompatibility complex class II competitor peptides results not only in a suppressed but also in an altered immune responseM H Wauben, A C Hoedemaekers, Y M Graus, et al.
Muscle & Nerve|September 1, 1997
Age-related susceptibility to experimental autoimmune myasthenia gravis: immunological and electrophysiological aspectsA C Hoedemaekers, J J Verschuuren, F Spaans, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
Nederlands Tijdschrift Voor Geneeskunde|November 22, 2019
[Elderly patients in the ICU: extending life to the max?]C Hoedemaekers
Immunologic Research|January 1, 1997
Myasthenia gravis as a prototype autoimmune receptor diseaseA C Hoedemaekers, P J van Breda Vriesman, M H De Baets
European Journal of Immunology|December 1, 1996
Inhibition of experimental autoimmune myasthenia gravis by major histocompatibility complex class II competitor peptides results not only in a suppressed but also in an altered immune responseM H Wauben, A C Hoedemaekers, Y M Graus, et al.
Muscle & Nerve|September 1, 1997
Age-related susceptibility to experimental autoimmune myasthenia gravis: immunological and electrophysiological aspectsA C Hoedemaekers, J J Verschuuren, F Spaans, et al.
Pageof 1